Download PDF
TumorDiagnostik & Therapie 2017; 38(06): 357-362
DOI: 10.1055/s-0043-107675
Schwerpunkt Tumoren der Nieren und ableitenden Harnwege
© Georg Thieme Verlag KG Stuttgart · New York

Diagnostische Möglichkeiten in der Bildgebung des Nierenzellkarzinoms

Mike Notohamiprodjo
,
Sascha Kaufmann
,
Gerwin Schmidt
Further Information

Publication History

Publication Date:
03 August 2017 (online)

Also available at
    Permissions and Reprints

Die Bildgebung der Niere hat in den letzten Jahren enorme Fortschritte erzielt. Dieser Beitrag gibt einen Überblick über die zurzeit zur Verfügung stehenden radiologischen Techniken zur Bildgebung von Nierentumoren und diskutiert in Entwicklung befindliche Techniken.
 

  • Literatur

  • 1 Clevert DA. et al. Modern imaging of kidney tumors. Urologe A 2013; 52: 515-526
    CrossrefPubMedGoogle Scholar
  • 2 Braunagel M. et al. The role of functional imaging in the era of targeted therapy of renal cell carcinoma. World J Urol 2014; 32: 47-58
    CrossrefPubMedGoogle Scholar
  • 3 Notohamiprodjo M. et al. Imaging of Metastastic Renal Cell Carcinoma under Therapy with Immune Checkpoint Inhibitors. Fortschr Röntgenstr 2017; 189: 287-292
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Rummeny EJ. Ganzkörper-MR-Tomografie. Stuttgart: Thieme; 2006 3. Auflage.
    PubMedGoogle Scholar
  • 5 Reznek RH. CT/MRI in staging renal cell carcinoma. Cancer Imag 2004; 4: S25-S32
    CrossrefPubMedGoogle Scholar
  • 6 Kreft BP. et al. Diagnostic value of MR imaging in comparison to CT in the detection and differential diagnosis of renal masses: ROC analysis. Europ Radiol 1997; 7: 542-547
    CrossrefPubMedGoogle Scholar
  • 7 Henrichs B, Walsh RP. Intraoperative magnetic resonance imaging for neurosurgical procedures: anesthetic implications. AANA J 2011; 79: 71-77
    PubMedGoogle Scholar
  • 8 Baikoussis NG. et al. Safety of magnetic resonance imaging in patients with implanted cardiac prostheses and metallic cardiovascular electronic devices. Annals Thora Surg 2011; 91: 2006-2011
    PubMedGoogle Scholar
  • 9 Sun MR. et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes-correlation with pathologic findings. Radiol 2009; 250: 793-802
    CrossrefPubMedGoogle Scholar
  • 10 Thomsen HS. et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Europ Radiol 2013; 23: 307-318
    CrossrefPubMedGoogle Scholar
  • 11 Nephrogenic systemic Fibrosis (NSF), in ACR Manual on Contrast Media. 2012: 63-71
    PubMedGoogle Scholar
  • 12 Wang Y. et al. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiol 2011; 260: 105-111
    CrossrefPubMedGoogle Scholar
  • 13 Radbruch A. et al. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiol 2015; 275: 783-791
    CrossrefPubMedGoogle Scholar
  • 14 www.mrisafety.com
    PubMed
  • 15 Ganeshan D. et al. Recent advances in cross-sectional renal imaging-an oncologic perspective: the current concepts and the future challenges. J Comput Assist Tomogr 2013; 37: 962-970
    CrossrefPubMedGoogle Scholar
  • 16 Ruppert-Kohlmayr AJ. et al. Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. Am J Roentgenol 2004; 183: 1387-1391
    CrossrefPubMedGoogle Scholar
  • 17 Karlo CA. et al. MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters. Europ Radiol 2013; 23: 1738-1744
    CrossrefPubMedGoogle Scholar
  • 18 Karlo CA. et al. Renal Cell Carcinoma: Role of MR Imaging in the Assessment of Muscular Venous Branch Invasion. Radiol 2013; 267: 454-459
    CrossrefPubMedGoogle Scholar
  • 19 Notohamiprodjo M. et al. Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast-enhanced MRI: a pilot study. J Magn Reson Imag 2010; 31: 490-501
    CrossrefPubMedGoogle Scholar
  • 20 Notohamiprodjo M. et al. Diffusion tensor imaging (DTI) of the kidney at 3 tesla-feasibility, protocol evaluation and comparison to 1.5 Tesla. Invest Radiol 2010; 45: 245-254
    CrossrefPubMedGoogle Scholar
  • 21 Winter KS. et al. Dynamic contrast-enhanced magnetic resonance imaging assessment of kidney function and renal masses: single slice versus whole organ/tumor. Invest Radiol 2014; 49: 720-727
    CrossrefPubMedGoogle Scholar